Non-Randomized
Showing 1 - 25 of >10,000
Safety Issues, Effect of Drug Trial in Yogyakarta, Jakarta, Bali (Enoxaparin sodium injection)
Recruiting
- Safety Issues
- Effect of Drug
- Enoxaparin sodium injection
-
Yogyakarta, D.I.Yogyakarta, Indonesia
- +2 more
Oct 29, 2023
PTCL Patients Who Achieved Complete Response From Frontline Treatment Trial (Selinexor)
Not yet recruiting
- PTCL Patients Who Achieved Complete Response From Frontline Treatment
- (no location specified)
Apr 18, 2023
NSCLC Trial (Atezolizumab, Tiragolumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- (no location specified)
Apr 11, 2023
Coronary Artery Disease Obliterative, Chronic Total Occlusion (CTO) Trial in Tbilisi, Athens, Singapore (Microcatheter)
Completed
- Coronary Artery Disease Obliterative
- Chronic Total Occlusion (CTO)
- Microcatheter
-
Tbilisi, Georgia
- +6 more
Sep 1, 2023
Non-valvular Atrial Fibrillation Trial in Aalst (Percutaneous LAA Closure)
Active, not recruiting
- Non-valvular Atrial Fibrillation
- Percutaneous LAA Closure
-
Aalst, BelgiumOLV Hospital
Dec 27, 2022
A Non-randomized, Open-Label Study to Evaluate Safety and
Not yet recruiting
- Lymphedema
- +3 more
- Insight Pro Device for Diagnosis
- (no location specified)
Nov 28, 2022
CMV Viremia Trial (Letermovir Pill)
Not yet recruiting
- CMV Viremia
- Letermovir Pill
- (no location specified)
Jun 20, 2022
Diabetes Trial in Ulm (Prototype 0.5)
Not yet recruiting
- Diabetes Mellitus
- Prototype 0.5
-
Ulm, GermanyInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsg
May 8, 2023
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023
EBRA Study AMISTEM-C FR
Active, not recruiting
- Total Hip Arthroplasty
-
Arras, FranceHôpital privé Arras Les Bonnettes
May 4, 2023
Unrecognized Condition Trial in Kuopio (Robot for madication management)
Completed
- Unrecognized Condition
- Robot for madication management
-
Kuopio, FinlandRiitta Turjamaa
Jun 10, 2023
Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)
Not yet recruiting
- Ovarian Cancer
- Olaparib tablet
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Nov 1, 2023
Hepatic Impairment Trial (Elacestrant diHCl)
Not yet recruiting
- Hepatic Impairment
- Elacestrant dihydrochloride
- (no location specified)
Nov 6, 2023
Hypothyroidism Trial (levothyroxine sodium)
Not yet recruiting
- Hypothyroidism
- levothyroxine sodium
- (no location specified)
Apr 9, 2023
Pain Trial in Seville (Painless Vaccination)
Completed
- Pain
- Painless Vaccination
-
Seville, Andalucia, SpainDistrito Sanitario Aljarafe-Sevilla Norte
Aug 16, 2023
Multicenter Mpact DM France
Recruiting
- Total Hip Arthroplasty
- Survival, Prosthesis
-
Dracy-le-Fort, FranceCentre Orthopédique Médico-Chirurgical de Dracy Le Fort
Apr 18, 2023
Renal Dialysis Trial (Levocarnitine Injection)
Not yet recruiting
- Renal Dialysis
- Levocarnitine Injection
- (no location specified)
Jan 3, 2023
Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)
Active, not recruiting
- Non-alcoholic Fatty Liver Disease
- +5 more
- AZD7503 Intervention
-
San Antonio, TexasResearch Site
Jan 13, 2023
Injectable Contraception Cohort Study in Punjab, Pakistan
Not yet recruiting
- Contraceptive Usage
- Contraceptive usage
- (no location specified)
Mar 7, 2023
0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in
Not yet recruiting
- Post Operative Endophthalmitis
- Moxifloxacin hydrochloride ophthalmic solution
- (no location specified)
Jan 11, 2023